~~<i id='1F08349A29'><strike id='1F08349A29'><tt id='1F08349A29'><pre id='1F08349A29'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：leisure time 2025-09-06 04:35:43 - browse：7624

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Setback for rare diseases as Taysha Gene Therapies pulls back

leisure time

explore

leisure time

focus

entertainment

leisure time

AdobeNewscientificinstitutesarespringingupallovertheplacethesedays:ArcadiaScience,NewScience,ArcInst

WSS

Some top drug companies are starting to take action on climate

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Adele warns fans about throwing things at performers onstage

China dismisses criticism of top diplomat's comments appearing to push for race

Pope Francis asks Church to identify 21st

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Wikipedia

hotspot

leisure time

Drug repurposing or repositioning? The language matters

RSV injection headlines need to be accurate for good uptake

Medicare details structure of new drug price negotiation program

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

United colonoscopy coverage change 'may cost lives,' doctors say

5 shark bites reported on Long Island as officials deploy surveillance drones

New air purifier tech could be key to improving indoor air quality

Flu, Covid vaccination rates decline, new survey data show

Affirmative action in medical school literally saved lives

New oral drug delivery patch is modeled after octopus tentacles

explore

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Stop Congress from blocking public access to science

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

IVG is promising — but it won’t replace IVF quite yet

leisure time

focus

entertainment

leisure time